| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-02-01 | FY 2023
FILED 2024-02-03 |
|---|---|---|---|
| Revenue (Total Sales) | $596.5M | $610.9M | $608.0M |
| YoY Revenue Growth % | -2.3% | +0.5% | — |
| Gross Profit | $409.7M | $429.9M | — |
| Gross Margin % | 68.7% | 70.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $50.6M | $75.7M | $86.0M |
| Operating Margin % | 8.5% | 12.4% | 14.2% |
| Net Income (GAAP) | $27.9K | $39.5K | $36.2K |
| EBITDA (Normalized) | $64.2M | $87.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $42.1M | $65.0M | $63.3M |
| Capital Expenditures (CapEx) | $16.9M | $14.3M | — |
| Free Cash Flow (FCF) | $25.2M | $50.8M | $63.3M |
| FCF Margin % | 4.2% | 8.3% | 10.4% |
| Return on Invested Capital (ROIC %) | 26.3% | 85.0% | — |
| Cash & Short-Term Equivalents | $41.0M | $35.4M | — |
| Total Debt (Short + Long Term) | $71.4M | — | — |
| Total Stockholders' Equity | $121.5M | $105.8M | — |